The CaMKII K42M and K42R mutations are equivalent in suppressing kinase activity and targeting

• Jonathan E. Tullis,

  Roles Conceptualization, Formal analysis, Investigation, Methodology, Visualization, Writing – review & editing

  Affiliation Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America

  ⨯
• Nicole L. Rumian,

  Roles Conceptualization, Formal analysis, Investigation, Methodology, Writing – review & editing

  Affiliations Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America, Program in Neuroscience, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America

  http://orcid.org/0000-0002-4327-1930

  ⨯
• Carolyn Nicole Brown,

  Roles Conceptualization, Investigation, Visualization, Writing – review & editing

  Affiliation Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America

  ⨯
• K. Ulrich Bayer

  Roles Conceptualization, Funding acquisition, Visualization, Writing – original draft

  * E-mail: ulli.bayer@ucdenver.edu

  Affiliations Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America, Program in Neuroscience, University of Colorado Anschutz Medical Campus, Aurora, CO, United States of America

  http://orcid.org/0000-0003-0893-2200

  ⨯